Recorded Chinese product: 牛磺酸颗粒牛磺酸颗粒
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 赤峰万泽制药有限责任公司Chinese legal name: 赤峰万泽制药有限责任公司
主要成分Active Ingredients
- 葡萄糖Putao Tang
- 纤维素Xianwei Su
- 柠檬黄Ningmeng Huang
- 辅料为:蔗糖Recorded Chinese composition: 辅料为:蔗糖
药物知识说明
葡萄糖是一种在国家药监局注册认定的药品。该药品含有柠檬黄、纤维素、葡萄糖-31b6cd73等成分。
该药品关联的活性成分包括：柠檬黄Ningmeng Huang、纤维素Xianwei Su、葡萄糖Putao Tang。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：赤峰万泽制药有限责任公司Chinese legal name: 赤峰万泽制药有限责任公司。
您可以探索含有相同成分的其他药品：柠檬黄-70aae3f8成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 牛磺酸颗粒) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 柠檬黄Ningmeng Huang, 纤维素Xianwei Su, 葡萄糖Putao Tang.
Manufacturers recorded for this product: 赤峰万泽制药有限责任公司Chinese legal name: 赤峰万泽制药有限责任公司.
Explore other medicines containing the same ingredient: 柠檬黄 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 牛磺酸颗粒Recorded Chinese product: 牛磺酸颗粒
- 剂型Dosage form: 颗粒剂Granules
- 规格Specification: 0.4g0.4 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 赤峰万泽制药有限责任公司Chinese legal name: 赤峰万泽制药有限责任公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H19993892
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H19993892
Manufacturer
Chinese legal name: 赤峰万泽制药有限责任公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H19993892
生产企业
赤峰万泽制药有限责任公司(国产)
适应症
用于缓解感冒初期的发热。
用法用量
口服。一次用量： 1.1～2岁1包。 2.3-5岁1.5包。 3.6-8岁2包。 4.9-13岁2.5～3包。 5.14岁以上儿童及成人3～4包，一日3次。
不良反应
尚不明确。
禁忌
对本品过敏者禁用。
注意事项
1、本品为症治疗药，连续应用不得超过3天，症状未缓解请咨询医师或药师。
2、仅限于感冒初起、热度不高的患者。
3、当本品性状发生改变时禁用。
4、如服用过量或出现严重不良反应时应立即就医。
5、儿童必须在成人监护下使用。
6、请将此药品放在儿童不能接触的地方。
贮藏
密封，置阴凉处。
规格
0.4g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.